Childhood, adolescent, and young adult cancer survivors treated with cranial radiotherapy have an increased risk of subsequent central nervous system neoplasms. Because of this high risk survivors should be counselled.
Quality of LifeAllGuidelines
IGHG Guideline on Central Nervous System Neoplasms
Recommendations for surveillance for central nervous system neoplasms in survivors who were treated with cranial radiotherapy.
Published:
Continue reading · Quality of LifeIGHG Ototoxicity GuidelineRecommendations for surveillance for ototoxicity (hearing loss, tinnitus, or both) in survivors who were treated with platinum chemotherapy or radiotherapy to the brain or ear.
Discussion & Questions
Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.
Leave a Comment
No comments yet
Be the first to share your thoughts!
Related Resources
IGHG Ototoxicity Surveillance Recommendations
Recommendations for surveillance for ototoxicity in survivors who were treated with platinum chemotherapy or radiotherap...
Quality of LifeAll
Read
IGHG Survivor Information on Central Nervous System Neoplasms
Brochure on advantage and disadvantage of meningioma screening
Quality of LifeAll
Read
IGHG Guideline on Coronary Artery Disease Surveillance
Recommendations for surveillance for coronary artery disease in survivors
Quality of LifeAll
Read